US2009137778A1PendingUtilityA1
Replikin peptides and antibodies therefore
Est. expiryMar 27, 2021(expired)· nominal 20-yr term from priority
C07K 14/195C07K 14/385C07K 14/30A61P 31/12C07K 14/44A61P 31/04C07K 14/36C07K 14/21C07K 14/28A61P 33/06C07K 14/445A61K 2039/505C07K 14/205C07K 14/315C07K 14/39C07K 14/245C07K 14/355C07K 14/285A61K 2039/53C07K 14/305C07K 14/33C07K 14/345C07K 14/22C12N 2760/16122C12N 2760/16022C07K 14/005C07K 14/47C07K 14/415C07K 14/255C07K 14/38C07K 14/32C12N 2710/24122C07K 14/26A61K 38/00C07K 14/405C07K 14/34A61P 31/16C07K 14/35C07K 14/27C07K 14/335C07K 14/31C07K 14/24C07K 14/37C07K 14/40A61K 39/00Y02A50/30
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a new class of peptides related to rapid replication and their use in diagnosing, preventing and treating disease.
Claims
exact text as granted — not AI-modified1 - 173 . (canceled)
174 . A peptide consisting of 23 to 50 amino acid residues comprising any one of the sequences disclosed in the variable amino acid sequence of SEQ ID NO: 698.
175 . The peptide of claim 174 wherein said peptide is an HIV peptide.
176 . The peptide of claim 175 wherein said HIV peptide is a trans-activator peptide.
177 . The peptide of claim 174 consisting of 23 amino acid residues.
178 . A peptide consisting of 19 to 50 amino acid residues comprising any one of the sequences beginning at position 5 and ending at position 23 of the variable amino acid sequence of SEQ ID NO: 698.
179 . The peptide of claim 178 wherein said peptide is an HIV peptide.
180 . The peptide of claim 179 wherein said HIV peptide is a trans-activator peptide.
181 . The peptide of claim 178 consisting of 19 amino acid residues.Join the waitlist — get patent alerts
Track US2009137778A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.